SCHEMBL29445705

SCHEMBL29445705

C[N+]1=Cc2ccccc2CC1.Cc1ccc(S(=O)(=O)[O-])cc1

nearest known ligand 0.66

Known targets — ChEMBL curated mechanism

CHRM1CHRM2CHRM3CHRM4CHRM5SLC6A2dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 3/20 0.66
MAOA P21397 2/20 0.41
LMNA P02545 3/20 0.41
GAA P10253 1/20 0.37
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
MAPK1 P28482 1/20 0.36
THPO P40225 1/20 0.36
HTT P42858 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
BCHE P06276 1/20 0.35
ACHE P22303 1/20 0.35
MAPT P10636 1/20 0.35
RECQL P46063 1/20 0.35
PSEN1 P49768 2/20 0.35
PSEN2 P49810 2/20 0.35
APH1B Q8WW43 2/20 0.35
NCSTN Q92542 2/20 0.35
APH1A Q96BI3 2/20 0.35
PSENEN Q9NZ42 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL147387 1.00 MAOB (0.66) MAOBMAOALMNAGAACYP3A4
SCHEMBL148925 0.93 MAOB (0.68) MAOBMAOALMNAGAACYP3A4
Sulfuric Acid SCHEMBL141163 0.86 MAOB (0.77) MAOBMAOALMNACYP2D6BCHE
Sulfuric Acid SCHEMBL141164 0.85 MAOB (0.74) MAOBMAOALMNACYP2D6BCHE
SCHEMBL9011427 0.83 MAOB (0.62) MAOBMAOALMNACYP2D6HTT
SCHEMBL8008700 0.82 MAOB (0.70) MAOBMAOALMNAGAACYP2D6
SCHEMBL31231150 0.81 MAOB (1.00) MAOBMAOALMNACYP2D6HTT
SCHEMBL30311 0.81 MAOB (1.00) MAOBMAOALMNACYP2D6HTT
Bromide SCHEMBL1821620 0.79 MAOB (0.96) MAOBMAOALMNACYP2D6HTT
SCHEMBL8530667 0.79 MAOB (0.96) MAOBMAOALMNACYP2D6HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106459939-B Lipase variants and polynucleotides encoding same 诺维信公司 2026-05-22 CN disclosed
US-20260132388-A1 LIPASE VARIANTS AND MICROCAPSULE COMPOSITIONS COMPRISING SUCH LIPASE VARIANTS NOVOZYMES A/S (DK) 2026-05-14 US disclosed
EP-4717756-A2 LIPASE VARIANTS AND DETERGENT COMPOSITIONS Novozymes A/S (DK) 2026-04-01 EP disclosed
US-12559736-B2 Lipase variants and polynucleotides encoding same NOVOZYMES A/S (DK) 2026-02-24 US disclosed
US-12529017-B2 Detergent composition comprising a lipase NOVOZYMES A/S (DK) 2026-01-20 US disclosed
US-20250382594-A1 METHODS OF REDUCING ODOR NOVOZYMES A/S (DK) 2025-12-18 US disclosed
US-12492387-B2 Lipase variants and microcapsule compositions comprising such lipase variants NOVOZYMES A/S (DK) 2025-12-09 US disclosed
US-20250368924-A1 LIPASE VARIANTS AND COMPOSITIONS COMPRISING SUCH LIPASE VARIANTS NOVOZYMES A/S (DK) 2025-12-04 US disclosed
US-12480107-B2 Lipase variants and the use thereof NOVOZYMES A/S (DK) 2025-11-25 US disclosed
US-12480108-B2 Methods of reducing odor Novozyms A/S (DK) 2025-11-25 US disclosed
US-11332725-B2 Lipase variants and microcapsule compositions comprising such lipase variants NOVOZYMES A/S (DK) 2022-05-17 US disclosed
US-20220145273-A1 LIPASE VARIANTS AND POLYNUCLEOTIDES ENCODING SAME NOVOZYMES A/S (DK) 2022-05-12 US disclosed
EP-3994255-A1 LIPASE VARIANTS AND COMPOSITIONS THEREOF Novozymes A/S (DK) 2022-05-11 EP disclosed
US-11326152-B2 Lipase variants, polynucleotides encoding same and the use thereof NOVOZYMES A/S (DK) 2022-05-10 US disclosed
US-11326153-B2 Alpha-amylase variants and polynucleotides encoding same NOVOZYMES A/S (DK) 2022-05-10 US disclosed
WO-2022090361-A2 LIPASE VARIANTS AND COMPOSITIONS COMPRISING SUCH LIPASE VARIANTS NOVOZYMES A/S (DK) 2022-05-05 WO disclosed
US-11312946-B2 Detergent compositions NOVOZYMES A/S (DK) 2022-04-26 US disclosed
CN-114292829-A Lipase variants and polynucleotides encoding same 诺维信公司 2022-04-08 CN disclosed
CN-114207123-A Lipase variants and compositions thereof 诺维信公司 2022-03-18 CN disclosed
US-11268076-B2 Lipase variants and polynucleotides encoding same NOVOZYMES A/S (DK) 2022-03-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12559736-B2 Lipase variants and polynucleotides encoding same LPL, PNLIP, LIPG MAOB 1080/4885MAOA 1184/4885LMNA 512/4885
US-11312946-B2 Detergent compositions DAGLB, ABHD16A, DAGLA MAOB 3043/4885MAOA 3892/4885LMNA 521/4885
US-20260132388-A1 LIPASE VARIANTS AND MICROCAPSULE COMPOSITIONS COMPRISING SUCH LIPASE VARIANTS LIPE, LPL, PNLIP MAOB 1197/4885MAOA 1909/4885LMNA 977/4885
US-12529017-B2 Detergent composition comprising a lipase MGLL, LPL, LIPC MAOB 2721/4885MAOA 2245/4885LMNA 2201/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.